A5036817103- Blood Pressure and Hypertension Studies
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Health and Mental Health
- Global Public Health Policies and Epidemiology
- Health and Lifestyle Studies
- Acute Myocardial Infarction Research
- Pharmaceutical Practices and Patient Outcomes
- Sodium Intake and Health
- Heart Rate Variability and Autonomic Control
- Cardiovascular Health and Risk Factors
- Healthcare Systems and Public Health
- Acute Ischemic Stroke Management
- Hemodynamic Monitoring and Therapy
- Aging, Health, and Disability
- Muscle and Compartmental Disorders
- Cardiovascular and exercise physiology
- Health Promotion and Cardiovascular Prevention
- Public Health Policies and Education
- Trauma and Emergency Care Studies
- Chronic Disease Management Strategies
- Uterine Myomas and Treatments
- Pharmaceutical Economics and Policy
- Forensic Toxicology and Drug Analysis
- Nutritional Studies and Diet
- Medication Adherence and Compliance
World Health Organization Regional Office for the Americas
2022-2025
ORCID
2022-2024
Hospital El Cruce
2020-2021
Ministerio de Salud
2020-2021
Hospital de Niños de la Santísima Trinidad
2013
Mitre (United States)
2013
Global Hearts is the flagship initiative of World Health Organization to reduce burden cardiovascular diseases, leading cause death and disability worldwide. HEARTS in Americas Initiative regional adaptation that envisions as model for disease risk management, including hypertension diabetes, primary health care by 2025. This entering its sixth year implementation now includes 22 countries 1 380 centers. The objectives this report are three-fold. First, it describes emergence main elements...
Abstract Hypertension is the leading risk factor for cardiovascular disease (CVD) worldwide. Despite availability of effective antihypertensive medications, control hypertension at a global level dismal, and consequently, CVD burden continues to increase. In response, countries in Latin America Caribbean are implementing HEARTS Americas, community‐based program that focuses on increasing secondary prevention through mitigation. One key pillar implementation standardized treatment protocol...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in Americas, hypertension most significant modifiable risk factor. However, control rates remain low, CVD stagnant or rising after decades continuing reduction. In 2016, World Health Organization (WHO) launched HEARTS technical package to improve control. The Pan American (PAHO) designed Americas Initiative management, emphasizing control, date implemented 21 countries.
HEARTS in the Americas is regional adaptation of World Health Organization's Global Hearts Initiative, which will be model for risk management cardiovascular disease (CVD) primary health care Region by 2025. It has already been implemented 21 countries and 1045 centers throughout Latin America Caribbean. takes a public systems approach to systematically introduce simplified interventions at level focuses on hypertension as clinical entry point. This paper introduces new, improved application...
HEARTS in the Americas is regional adaptation of WHO Global Initiative. It implemented 24 countries and over 2,000 primary healthcare facilities. This paper describes results a multicomponent, stepwise, quality improvement intervention designed by to support advances hypertension treatment protocols evolution towards Clinical Pathway.The comprised: 1) use appraisal checklist evaluate current protocols, 2) peer-to-peer review consensus process resolve discrepancies, 3) proposal clinical...
Abstract Global HEARTS is a WHO initiative for cardiovascular disease prevention and control. Accurate blood pressure (BP) measurement an essential component of the initiative. This study aimed to determine regulatory frameworks governing accuracy BPMDs in countries Americas participating Quantitative qualitative analysis laws regulations relevant ensuring were determined from Ministries Health/Regulatory Agencies among 13 Latin America Caribbean. Analysis included characterizing scope (ie,...
<title>ABSTRACT</title> Hypertension and diabetes are modifiable cardiovascular disease (CVD) risk factors that contribute to nearly one-third of all deaths in the Americas Region each year (2.3 million deaths). Despite advances detection clinical management hypertension diabetes, there substantial gaps their implementation globally Region. The considerable overlap factors, prognosis, treatment creates a unique opportunity for unified model at population level. This report highlights one...
Cardiovascular diseases are the leading cause of mortality and morbidity in Region Americas, hypertension represents its main risk factor. However, population control rates poor. Global Hearts is World Health Organization's flagship initiative to reduce burden cardiovascular diseases. HEARTS Americas Initiative regional adaptation that seeks be disease management model, including diabetes, primary health care throughout by 2025. being implemented 22 countries over 2 095 centers. All...
Las enfermedades cardiovasculares son la principal causa de muerte en Región las Américas y hipertensión es más del 50% ellas. En Región, una cuarta parte mujeres adultas cuatro cada diez hombres adultos tienen su diagnóstico, tratamiento control deficientes. el 2021, Organización Mundial Salud (OMS) publicó directrices actualizadas sobre farmacológico personas adultas. este artículo se destaca papel facilitador iniciativa mundial HEARTS OMS para catalizar implementación estas directrices, a...
A doença cardiovascular (DCV) é a principal causa de morte nas Américas, e pressão arterial elevada responsável por mais 50% dos casos DCV. Nas um quarto das mulheres adultas quatro cada dez homens adultos têm hipertensão arterial, sendo que diagnóstico, tratamento controle estão abaixo do ideal. Em 2021, Organização Mundial da Saúde (OMS) divulgou uma atualização diretrizes para o medicamentoso em adultos. Esta publicação ressalta papel facilitador iniciativa Global HEARTS OMS Américas...
La Iniciativa Mundial HEARTS. es la iniciativa emblemática de Organización Salud para reducir carga las enfermedades cardiovasculares, principal causa muerte y discapacidad en todo el mundo. HEARTS Américas adaptación regional que propone usar como modelo manejo del riesgo incluida hipertensión, diabetes atención primaria salud Región año 2025. Esta está iniciando su sexto aplicación ya incluye a 22 países 1 380 centros salud. Este informe tiene tres objetivos. En primer lugar, describir...
Background: Hypertension control is suboptimal globally. Implementing evidence-based, simple, standardized treatment protocols (STPs) has been instrumental in effectively and efficiently improving of hypertension. We aimed to identify, characterize, critically appraise hypertension STPs. Methods: defined STP as a series steps for the pharmacological primary hypertension, with information on target population, BP threshold initiation, BP, specific drugs/classes/doses, follow-up frequency....
Introduction Hypertension significantly impacts the global cardiovascular disease burden, presenting a pronounced challenge within Latin America and Caribbean. The Pan American Health Organization's (PAHO) HEARTS initiative endeavours to meet this by enhancing comprehensive risk management, inclusive of improved access antihypertensive medications. This study scrutinises challenges barriers in accessing these medications, which are crucial for effective hypertension management regions.
Background: Adherence to treatment after a myocardial infarction (MI) is poor, even in the early postinfarction period. Combining evidence-based drugs into multicap could improve adherence this population. No previous randomized trial assessing fixed-dose combination therapy has included patients MI. We aimed assess if containing four secondary prevention increases at 6 months MI hospitalization. The study was designed as randomized, parallel, open-label, controlled trial. Methods: Patients...
HEARTS en las Américas es la adaptación regional de iniciativa Global Organización Mundial Salud, que será el modelo para manejo del riesgo enfermedades cardiovasculares (ECV) atención primaria salud Región año 2025. Ya se ha implementado 21 países y 1045 centros toda América Latina Caribe. Se adoptado un enfoque pública sistemas introducir sistemáticamente intervenciones simplificadas nivel centran control hipertensión como punto entrada clínico. En este artículo presenta una aplicación...
<sec> <title>Antecedentes.</title> Las enfermedades cardiovasculares (ECV) son la principal causa de morbilidad y mortalidad en Región las Américas hipertensión es el factor riesgo modificable asociado más importante. Sin embargo, tasas control siguen siendo bajas por ECV está estancada o aumento después décadas reducción continua. En 2016, Organización Mundial Salud (OMS) presentó paquete técnico HEARTS para mejorar hipertensión. La Panamericana (OPS) diseñó iniciativa del ECV, que hace...
<title>ABSTRACT</title> HEARTS in the Americas is Pan American Health Organization flagship program to accelerate reduction of cardiovascular disease (CVD) burden by improving hypertension control and CVD secondary prevention primary health care. A monitoring evaluation (M&E) platform needed for implementation, benchmarking, informing policy-makers. This paper describes conceptual bases M&E including software design principles, contextualization data collection modules, structure,...
La hipertensión y la diabetes son los factores de riesgo modificables las enfermedades cardiovasculares asociados a casi un tercio todas muertes en Región Américas cada año (2,3 millones). A pesar avances detección el manejo clínico diabetes, existen brechas sustanciales implementación nivel regional mundial. El considerable solapamiento riesgo, pronóstico tratamiento crea una oportunidad única para modelo unificado poblacional. En este informe se pone relieve iniciativa importante tipo,...